Trial
NCT04800822
PF-07284892 in Participants With Advanced Solid Tumors
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Pfizer
Collaborators
—
Condition
Solid Tumor
Intervention
PF-07284892
Why stopped
The study was prematurely discontinued due to strategic reasons. The PF-07284892 program will continue
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-04